Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,754,095 | 907,174 | 2,566,807 | 2,154,512 | 919,184 |
| Marketable Securities | 56,612 | 221,033 | 274,404 | 271,272 | 319,444 |
| Receivables | 3,303,971 | 3,597,620 | 3,387,878 | 2,893,924 | 3,083,613 |
| Inventories | 1,900,665 | 1,862,861 | 2,024,953 | 2,008,730 | 1,966,476 |
| TOTAL | $7,015,343 | $6,588,688 | $8,254,042 | $7,328,438 | $6,288,717 |
| Non-Current Assets | |||||
| PPE Net | 3,502,262 | 3,557,142 | 4,125,149 | 4,024,936 | 4,074,479 |
| Investments And Advances | 329,449 | 279,399 | 152,625 | 146,850 | 141,710 |
| Intangibles | 216,372 | 207,995 | 245,697 | 248,844 | 314,114 |
| Other Non-Current Assets | 987,160 | 1,109,257 | 962,642 | 939,306 | 885,548 |
| TOTAL | $5,035,243 | $5,153,793 | $5,486,113 | $5,359,936 | $5,415,851 |
| Total Assets | $12,050,590 | $11,742,480 | $13,740,150 | $12,688,370 | $11,704,570 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 109,075 | 90,050 | 128,376 | 50,552 | 74,623 |
| Accounts payable and accrued liabilities | 582,722 | 608,522 | 882,585 | 531,864 | 549,194 |
| Other current liabilities | 4,548,406 | 5,176,988 | 4,501,718 | 4,199,554 | 3,462,976 |
| TOTAL | $5,719,482 | $6,365,532 | $6,006,749 | $5,345,518 | $4,364,882 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 532,038 | 503,009 | 547,738 | 583,128 | 520,154 |
| TOTAL | $534,854 | $509,376 | $548,986 | $584,730 | $601,394 |
| Total Liabilities | $6,254,336 | $6,874,908 | $6,555,734 | $5,930,248 | $4,966,276 |
| Shareholders' Equity | |||||
| Common Shares | 77,064 | 80,348 | 94,499 | 94,340 | 97,414 |
| Retained earnings | 5,832,115 | 5,274,164 | 7,359,689 | 6,896,254 | 6,636,099 |
| Other shareholders' equity | -111,929 | -484,939 | -267,768 | -230,468 | 5,779 |
| TOTAL | $5,796,250 | $4,867,573 | $7,184,420 | $6,758,126 | $6,738,292 |
| Total Liabilities And Equity | $12,050,586 | $11,742,481 | $13,740,154 | $12,688,374 | $11,704,568 |